Cas no 1328640-39-6 (ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate)

Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate is a versatile heterocyclic building block used in organic synthesis and pharmaceutical research. This compound features a bromine substituent at the 4-position and an ester group at the 5-position, making it a valuable intermediate for further functionalization via cross-coupling reactions or nucleophilic substitutions. The 1-methyl group enhances stability while maintaining reactivity. Its pyrazole core is significant in medicinal chemistry due to its prevalence in bioactive molecules. The ester moiety allows for straightforward derivatization into acids, amides, or other functional groups. This reagent is particularly useful in the synthesis of agrochemicals, pharmaceuticals, and advanced materials, offering a balance of reactivity and handling stability.
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate structure
1328640-39-6 structure
Product Name:ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
CAS No:1328640-39-6
MF:C7H9BrN2O2
MW:233.062560796738
MDL:MFCD20491534
CID:2126262
PubChem ID:60136527
Update Time:2025-06-25

ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate Chemical and Physical Properties

Names and Identifiers

    • ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
    • DA-12275
    • ethyl 4-bromo-2-methyl-pyrazole-3-carboxylate
    • AKOS015920741
    • ethyl 4-bromo-2-methylpyrazole-3-carboxylate
    • MBLKICOIMWDSJT-UHFFFAOYSA-N
    • 1328640-39-6
    • DS-9917
    • Z1322794799
    • MFCD20491534
    • SCHEMBL16177307
    • ethyl4-bromo-1-methyl-1H-pyrazole-5-carboxylate
    • EN300-232695
    • STL583969
    • DDC64039
    • MDL: MFCD20491534
    • Inchi: 1S/C7H9BrN2O2/c1-3-12-7(11)6-5(8)4-9-10(6)2/h4H,3H2,1-2H3
    • InChI Key: MBLKICOIMWDSJT-UHFFFAOYSA-N
    • SMILES: BrC1C=NN(C)C=1C(=O)OCC

Computed Properties

  • Exact Mass: 231.98474g/mol
  • Monoisotopic Mass: 231.98474g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 12
  • Rotatable Bond Count: 3
  • Complexity: 177
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.5
  • Topological Polar Surface Area: 44.1?2

ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate Security Information

ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A049003018-1g
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6 95%
1g
401.88 USD 2021-05-31
Alichem
A049003018-5g
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6 95%
5g
1,204.62 USD 2021-05-31
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
E899322-5g
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6 ≥95%
5g
4,204.80 2021-05-17
Chemenu
CM248863-1g
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6 95%
1g
$204 2021-08-04
Chemenu
CM248863-5g
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6 95%
5g
$561 2021-08-04
TRC
E901533-50mg
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6
50mg
$ 70.00 2022-06-05
TRC
E901533-100mg
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6
100mg
$ 95.00 2022-06-05
TRC
E901533-500mg
ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6
500mg
$ 340.00 2022-06-05
abcr
AB455424-100 mg
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6
100MG
€176.40 2022-03-01
abcr
AB455424-250 mg
Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate
1328640-39-6
250MG
€198.50 2022-03-01

Additional information on ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate

Introduction to Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate (CAS No. 1328640-39-6)

Ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate (CAS No. 1328640-39-6) is a significant compound in the field of pharmaceutical and chemical research, renowned for its versatile applications in drug synthesis and molecular biology. This compound, characterized by its unique structural framework, has garnered considerable attention due to its potential in developing novel therapeutic agents and biochemical probes.

The molecular structure of ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate consists of a pyrazole core substituted with a bromine atom at the 4-position and a methyl group at the 1-position, further functionalized with a carboxylate ester group at the 5-position. This specific arrangement of functional groups makes it a valuable intermediate in organic synthesis, particularly in the construction of more complex molecules.

In recent years, the compound has been extensively studied for its role in the development of small-molecule inhibitors targeting various biological pathways. The bromine substituent, for instance, provides a reactive site for further chemical modifications, enabling the synthesis of a wide array of derivatives. These derivatives have shown promise in preclinical studies as potential candidates for treating conditions such as cancer, inflammation, and infectious diseases.

One of the most compelling aspects of ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate is its utility in medicinal chemistry. Researchers have leveraged its structural features to design molecules that interact with specific enzymes and receptors involved in disease processes. For example, studies have demonstrated its efficacy in inhibiting kinases, which are critical targets in oncology research. The ability to modify the pyrazole core allows for fine-tuning of pharmacokinetic properties, enhancing drug-like characteristics such as solubility and bioavailability.

The carboxylate ester group in ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate also plays a crucial role in its applications. This moiety can be hydrolyzed to form a free carboxylic acid, which can then be further functionalized through various chemical reactions such as esterification, amidation, or coupling reactions. This flexibility makes it an indispensable building block in the synthesis of more complex pharmaceuticals.

Recent advancements in computational chemistry have further highlighted the importance of ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate. Molecular modeling studies have revealed insights into how this compound interacts with biological targets at the atomic level. These insights have guided the design of more potent and selective inhibitors, paving the way for next-generation therapeutics.

The compound's significance extends beyond drug development. It has also been utilized in biochemical research as a tool for studying enzyme mechanisms and pathways. For instance, researchers have employed derivatives of ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate to probe the activity of cytochrome P450 enzymes, which are involved in drug metabolism. Such studies contribute to a better understanding of how drugs are processed in the body, aiding in the optimization of drug regimens.

In conclusion, ethyl 4-bromo-1-methyl-1H-pyrazole-5-carboxylate (CAS No. 1328640-39-6) is a multifaceted compound with broad applications in pharmaceutical chemistry and biological research. Its unique structural features and reactivity make it an invaluable tool for developing new drugs and understanding complex biological processes. As research continues to uncover new applications for this compound, its importance is likely to grow even further.

Recommended suppliers
Yunnanjiuzhen
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd